Vascular Dementia
86
14
17
44
Key Insights
Highlights
Success Rate
96% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
2.3%
2 terminated out of 86 trials
95.7%
+9.1% vs benchmark
19%
16 trials in Phase 3/4
20%
9 of 44 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 44 completed trials
Clinical Trials (86)
Retinal Hyperspectral Imaging in Neurodegenerative Diseases
Efficacy and Safety of Butylphthalide Soft Capsule for the Treatment of Vascular Dementia
Florida Cerebrovascular Disease Biorepository and Genomics Center
Retinal Vessel Leakage in Cerebral Small Vessel Disease
The Clinical Trial of Chinese Herbal Medicine (SaiLuoTong) Capsule
A Study That Collects Participant Data and Biospecimens to Analyze Pathogenic Exosomes That Mediate Increased Vascular Dementia Risk in Individuals With Herpes Zoster.
Predictors of Emergency Department Use in Frail Patients
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
Evaluation of Cerogrin for Auricular Vagus Nerve Stimulation in Vascular Dementia or Vascular Mild Cognitive Impairment
WeCareAdvisor Study for Caregivers of People Living With Dementia
Cognitive and Vascular Functioning Following TBI
Urolithin A Supplementation in Middle-aged Adults With Obesity
Care of Persons With Dementia in Their Environments (COPE) in Programs of All-Inclusive Care of the Elderly (PACE)
The BRAIN App (Phase 2 SBIR)
Imaging of Brain Amyloid Plaques in the Aging Population
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
Pulsed Electromagnetic Field Treatment With Dementia Patients
Learning and Coping With Early Stage Dementia
Novel Diagnostic and Disease Stage Biomarkers in AD
The Swedish BioFINDER Study